Changsheng Bio-Technology, which in a high-profile scandal earlier this year was revealed to have fabricated data on its vaccines for infants, has received an advance notification of mandatory delisting from the Shenzhen Stock Exchange.

The exchange described the vaccine-maker's illegal activities as “seriously damaging to national interests and public interests.”

In a separate announcement, the company said the China Securities Regulatory Commission fined 17 related personnel for market violations, banned four from entering China’s stock markets for life, and three from entering the market for five years.

Related: Data-Faking Vaccine Firm to Be Kicked Off Stock Exchange Under New Rules